Why did AYUR.CN stock fall so sharply on 31 Jan 2026?

AYUR.CN stock plunged after Ayurcann filed for creditor protection under the CCAA and announced a sale process. The CCAA filing, plus a CIRO trading halt and heavy selling, drove the one-day decline to C$0.005.

What is Meyka AI’s view and grade for AYUR.CN stock?

Meyka AI rates AYUR.CN with a score out of 100: 69.81, Grade B, Suggestion HOLD. The grade factors in benchmark and sector comparisons, growth and key metrics. This is informational, not investment advice.

What are realistic near-term price targets for AYUR.CN stock?

Meyka AI's forecast model projects a monthly target of C$0.03 and a one-year level of C$0.01728. These imply large percentage upside from C$0.005 but are model-based projections and not guarantees.

What should shareholders watch next for AYUR.CN stock?

Shareholders should monitor the Monitor’s website for sale process details, any court approvals of DIP financing, CSE listing status, and the company’s upcoming earnings announcement on 2026-03-04.

CA Stocks

AYUR.CN Ayurcann CNQ down 66.67% to C$0.005 on CCAA filing: sale process ahead

ByHuzaifa Zahoor January 31, 2026January 31, 2026

AYUR.CN stock dropped 66.67% to C$0.005 on 31 Jan 2026 during market hours after Ayurcann Holdings Corp. filed for creditor protection under the CCAA and announced a sale process. The move triggered a CIRO trading halt and a sharp surge in volume to 2,544,383 shares, far above the 50-day average of 84,668. We review the near-term catalysts, the company’s financial snapshot and what the filing means for shareholders on the Canadian (CNQ) market.